Kerry Logistics Network Commended for Comprehensive Climate Disclosure at the HKQAA Hong Kong Green and Sustainability Contribution Awards 2024by June 3, 2024PR Newswire
LOTTE rent-a-car employees recommend ‘Jeju Island’ as a domestic travel destinationby June 3, 2024PR Newswire
Kerry Logistics Network Named Global Logistics Company of Excellence by Hong Kong Economic Journal Corporate Brand Awards of Excellence 2024by June 3, 2024PR Newswire
เลนนี แครวิตซ์ ขึ้นแสดงโชว์สุดยิ่งใหญ่ เปิดการแข่งขันยูฟ่าแชมเปียนส์ลีกนัดชิงชนะเลิศ นำเสนอโดย PEPSI®by June 2, 2024PR Newswire
LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®by June 2, 2024PR Newswire
Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479by June 2, 2024PR Newswire
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024by June 2, 2024PR Newswire
Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meetingby June 2, 2024PR Newswire
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancerby June 2, 2024PR Newswire
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meetingby June 2, 2024PR Newswire
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meetingby June 2, 2024PR Newswire
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLCby June 2, 2024PR Newswire
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meetingby June 2, 2024PR Newswire
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meetingby June 2, 2024PR Newswire
Z Grills Announces Unprecedented “Buy 1, Get 10 Grills” Promotion, Unlocking a Lifetime of Easier Grilling!by June 1, 2024PR Newswire
ICECO Launches APL35 on Indiegogo – The World’s Lightest Aluminum Dual-Zone Freezerby June 1, 2024PR Newswire
Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Templeby June 1, 2024PR Newswire
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meetingby June 1, 2024PR Newswire
Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouseby June 1, 2024PR Newswire
Duke-NUS’ largest graduating cohort celebrates diverse pathways to medicineby June 1, 2024PR Newswire
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapyby June 1, 2024PR Newswire
Gold Pecker Leads the Way: First Expert Advisor to Offer ‘PAMM by Gold Pecker’ for Gold Tradersby June 1, 2024PR Newswire
Skymizer Launches Groundbreaking LLM Accelerator IP for on-device LLM Inferencing, EdgeThought, the game-changer in on-device GenAI era.by June 1, 2024PR Newswire
KED INVESTOR ALERT: Kaskela Law LLC Announces Investigation of Keypath Education International, Inc. (ASX: KED) and Encourages Investors to Contact the Firmby June 1, 2024PR Newswire
MingZhu Logistics Agrees to Acquire Oxylus Global; Company Targeting Continued Aggressive Diversification and Growth Acceleration Strategyby June 1, 2024PR Newswire
